483 Intas Pharmaceuticals Jun 2018

483 Intas Pharmaceuticals Jun 2018

Matthew Casale FDA, Abby Pelletier FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 08 Jun 2018.

Product details

  • Category: Animal Drugs & Feeds
  • Inspection end: 08 Jun 2018
  • Location: Ahmedabad, India
  • FEI: 3003157498
Add To Cart